"The Bharat Army, Team India's No.1 Global Supporters Group are proud to announce their association this #IndianSummer in Support of Yuvraj Singh's YouWeCan Foundation.
Bharat Army members around the world for many years have had the pleasure of witnessing Yuvraj represent his country with great pride, while at the same time giving people all over the world immense pleasure with his flamboyant style of cricket.
"Having supported Yuvraj throughout his career as a player and having tremendous admiration for what he has achieved on and off the field, I'm extremely happy The Bharat Army has an opportunity to continue supporting Yuvraj via the YOUWECAN Foundation and look forward to helping them meet their objectives". said the founder of The Bharat Army, Rakesh Patel
This Summer in England, The Bharat Army would like to thank Yuvraj for all his contribution while representing Team India and his country by helping raise Awareness and Funds for his noble YouWeCan Foundation.
“I am absolutely delighted to get the support of Bharat Army. As fans of Indian cricket they have supported us all across the world and now there members have come forward to support the agenda of YOUWECAN. I am sure like on the field they will make their presence felt here as well, I am looking forward to their support and contributions“ said Yuvraj Singh on this association.
Please visit www.bharat-army.com to find out how you can help The Bharat Army support The YouWeCan Foundation.
The Bharat Army look forward to a successful partnership, helping Yuvraj and the YouWeCan Foundation meet their short and long term goals and objectives".
Retinoblastoma rising among Indian children: AIIMS
Retinoblastoma, a rare type of eye cancer, is a fast emerging disease among Indian children, says leading eye specialists at the All India Institute of Medical Sciences (AIIMS).
They averred that though earlier the disease used to occur 1 in 20,000 live births but now the rise in the disease is such that every year over 20,000 new cases of retinoblastoma are being witnessed.
The opthalmologists stated that late diagnosis and misconceptions about the symptoms were the major reasons that the eye cancer even extended to the brain and then to the entire body, ultimately leaving no option of treatment for the patients.
"Retinoblastoma basically occurs among children below five years. This can be caused both genetically and non-genetically. The problem with Indian children is that due to lack of awareness the parents bring their children only after observing any thing major in the eyes of their children," said Bhavana Chawla, associate professor at RP Centre for Ophthalmic Sciences at AIIMS.
She was speaking to reporters during a discussion at AIIMS on the rise of retinoblastoma.
Noting that many people in India didn't recognise the symptoms of eye cancer due to lack of awareness, Chawla said that any patient with a white spot in the eye, squint or any type of shine in the eye balls should come and get tested for retinoblastoma.
She also said that in many cases it becomes difficult for doctors to save the eye sight which gets majorly affected during the disease.
Professor Pradeep Sharma at RP centre said that the major problem with Indians suffering from retinoblastoma is that they approach the doctors at a very late stage even though India has made some of the finest medical advancements in treating eye cancer.
"The Bharat Army, Team India's No.1 Global Supporters Group are proud to announce their association this #IndianSummer in Support of Yuvraj Singh's YouWeCan Foundation.
Bharat Army members around the world for many years have had the pleasure of witnessing Yuvraj represent his country with great pride, while at the same time giving people all over the world immense pleasure with his flamboyant style of cricket.
"Having supported Yuvraj throughout his career as a player and having tremendous admiration for what he has achieved on and off the field, I'm extremely happy The Bharat Army has an opportunity to continue supporting Yuvraj via the YOUWECAN Foundation and look forward to helping them meet their objectives". said the founder of The Bharat Army, Rakesh Patel
This Summer in England, The Bharat Army would like to thank Yuvraj for all his contribution while representing Team India and his country by helping raise Awareness and Funds for his noble YouWeCan Foundation.
“I am absolutely delighted to get the support of Bharat Army. As fans of Indian cricket they have supported us all across the world and now there members have come forward to support the agenda of YOUWECAN. I am sure like on the field they will make their presence felt here as well, I am looking forward to their support and contributions“ said Yuvraj Singh on this association.
Please visit www.bharat-army.com to find out how you can help The Bharat Army support The YouWeCan Foundation.
The Bharat Army look forward to a successful partnership, helping Yuvraj and the YouWeCan Foundation meet their short and long term goals and objectives".
Elderly cancer patient calls 911 because he is hungry and has no food, operator comes to his home and makes him sandwiches
An elderly cancer patient with no immediate family says he rang 911 because he did not have any food and was physically unable to leave his house to buy something to eat.
Hungry and unable to buy food, he called 911 and asked if someone could buy some groceries for him. "What I need is someone to get to the grocery store and bring me some food because I need to eat something,” Mr Blackmon told the operator. “Whatever you can do to help. I can’t do anything. I can’t go anywhere. I can’t get out of my damn chair.”
Former Toronto mayor Rob Ford regains consciousness after undergoing cancer surgery.
Doctors have removed a cancerous tumor from former Toronto Mayor Rob Ford's abdomen and he has regained consciousness after an intensive surgery that kept him under anesthesia for about 10 hours, his chief of staff said late Monday.
"There were no new growths, the cancer had not spread beyond what they were already aware of, and they were able to remove all the existing growths without causing damage to any internal structures," Dan Jacobs said in an e-mail.
Jacobs said doctors consider the procedure to be a success.
Ford, now a city councilman, is in "some pain," Jacobs said, and still has a long recovery ahead of him.
Dr. Carol Swallow—an expert in cancer surgery, including advanced and recurrent colorectal cancer-- lead a tean of four surgeons involved in Ford's operation.
Ford had said if chemotherapy and radiation failed to shrink the tumors in his abdomen to an operable size, his chance at survival was low. Jacobs said doctors will make two 11-inch incisions, to remove a two-inch tumor from Ford's body. The former mayor is expected to spend time in the post-operative recovery area before being transferred to the surgical stepdown unit.
Ford said he expected a four-month recovery from the surgery.
He was fighting for his political life to get re-elected as mayor when he checked into a hospital complaining of stomach pain in September, 2014. Doctors discovered the tumor, and he was soon diagnosed with liposarcoma, a rare cancer that begins in the fat cells. The disease-- considered a type of soft tissue sarcoma-- can occur in fat cells in any part of the body, but mostly occurs in the muscles of the limbs or in the abdomen, according to the Mayo Clinic website.
After the diagnosis, Ford dropped out of the mayoral race and put his name on the ballot in Ward 2 instead. He was elected as a councillor in the ward he represented before he became mayor in 2014. Candidate John Tory won the mayoral race—beating Ford’s brother, Doug Ford.
Rob Ford received international attention in 2013 when he was under pressure to resign as mayor after he admitted to smoking crack cocaine. He was also accused of inappropriate behavior and verbal abuse towards women, excessive alcohol use, cavorting with prostitutes and threatening to kill someone in a videotaped, incoherent rant. Ford denied many of the allegations.
At a city council meeting last week, Mayor Tory called Ford “a fighter” and said the council is pulling for him as he heads into surgery.
Ford staffer Dan Jacobs a tweeted a picture of the former mayor giving two thumbs-up while dressed in a hospital gown ahead of the operation.
---------------------------------------------------
Now, smartphone device can spot cancer faster!!!!!!
A smartphone-based device developed by researchers at Massachusetts General Hospital (MGH) can help doctors perform rapid and accurate molecular diagnosis of cancerous or non-cancerous tumours.
The device, called the D3 (digital diffraction diagnosis) system, features an imaging module with a battery-powered LED light clipped onto a standard smartphone that records high-resolution imaging data with its camera.
With a much greater field of view than traditional microscopy, the D3 system is capable of recording data on more than 100,000 cells from a blood or tissue sample in a single image.
The data can then be transmitted for analysis to a remote graphic-processing server via a secure, encrypted cloud service and the results rapidly returned to the point of care.
"We believe the platform we have developed provides essential features at an extraordinary low cost," said Cesar Castro, co-lead author of the report.
For molecular analysis of tumours, a sample of blood or tissue is labelled with microbeads that bind to known cancer-related molecules and loaded into the D3 imaging module.
After the image is recorded and data transmitted to the server, the presence of specific molecules is detected by analysing the diffraction patterns generated by the microbeads.
A pilot test of the system with cancer cell lines detected the presence of tumour proteins with an accuracy matching that of the current gold standard for molecular profiling, and the larger field of view enabled simultaneous analysis of more than 100,000 cells at a time.
"D3 analysis promptly and reliably categorised biopsy samples as high-risk, low-risk or benign with results matching those of conventional pathologic analysis," the authors noted.
In the pilot tests, results of the D3 assay were available in under an hour and at a cost of $1.80 per assay, a price that would be expected to drop with further refinement of the system.
"We expect that the D3 platform will enhance the breadth and depth of cancer screening in a way that is feasible and sustainable for resource limited-settings," added Ralph Weissleder, director of the MGH Center for Systems Biology (CSB) and co-senior author of the paper.
The report appeared in the journal PNAS Early Edition.
Brest Cancer Awarness Campaign held in Vadodara to mark Mother's Day
A local charitable trust organised a breast cancer awareness and check-up campaign in Vadodara to mark the Mother's Day on Sunday.
Organisers said the aim was to diagnose 100,000 women and spreading awareness about breast cancer.
If diagnosed with signs of breast cancer, the women would be made to undergo mammography tests.
The Sujal Charitable Trust proposes to fund the entire cost in case a woman is diagnosed with cancer and unable to meet expenses.
Dr. Preeti Niranjan, one of the doctors involved in the campaign, said they propose to urge women to diagnose themselves at home on a regular basis and undergo a yearly clinical check-up.
"Our women should be made aware that breast cancer can be diagnosed in the early stages itself through TAPAS methodology. In the United States, out of five women tested for breast cancer, one person dies whereas in India, the rate is much worse because the women in India turn up much late for diagnosis," said Dr. Preeti Niranjan.
Tajal Amin, also part of the campaign, said it was necessary to remove the inhibitions among Indian women about getting themselves checked for signs of breast cancer.
"Whether literate or not, most ladies in India are hesitant to get themselves diagnosed and by the time they actually visit a doctor, their tumour must have grown bigger. This campaign aims to make the ladies come out and get themselves checked. Its mission is to break the fear and hesitation in women and make more women come out and attend check-ups," said Amin.
About 112 hospitals, 550 doctors and paramedics and around 4000 volunteers have joined the initiative.
Former Toronto mayor Rob Ford regains consciousness after undergoing cancer surgery.
Doctors have removed a cancerous tumor from former Toronto Mayor Rob Ford's abdomen and he has regained consciousness after an intensive surgery that kept him under anesthesia for about 10 hours, his chief of staff said late Monday.
"There were no new growths, the cancer had not spread beyond what they were already aware of, and they were able to remove all the existing growths without causing damage to any internal structures," Dan Jacobs said in an e-mail.
Jacobs said doctors consider the procedure to be a success.
Ford, now a city councilman, is in "some pain," Jacobs said, and still has a long recovery ahead of him.
Dr. Carol Swallow—an expert in cancer surgery, including advanced and recurrent colorectal cancer-- lead a tean of four surgeons involved in Ford's operation.
Ford had said if chemotherapy and radiation failed to shrink the tumors in his abdomen to an operable size, his chance at survival was low. Jacobs said doctors will make two 11-inch incisions, to remove a two-inch tumor from Ford's body. The former mayor is expected to spend time in the post-operative recovery area before being transferred to the surgical stepdown unit.
Ford said he expected a four-month recovery from the surgery.
He was fighting for his political life to get re-elected as mayor when he checked into a hospital complaining of stomach pain in September, 2014. Doctors discovered the tumor, and he was soon diagnosed with liposarcoma, a rare cancer that begins in the fat cells. The disease-- considered a type of soft tissue sarcoma-- can occur in fat cells in any part of the body, but mostly occurs in the muscles of the limbs or in the abdomen, according to the Mayo Clinic website.
After the diagnosis, Ford dropped out of the mayoral race and put his name on the ballot in Ward 2 instead. He was elected as a councillor in the ward he represented before he became mayor in 2014. Candidate John Tory won the mayoral race—beating Ford’s brother, Doug Ford.
Rob Ford received international attention in 2013 when he was under pressure to resign as mayor after he admitted to smoking crack cocaine. He was also accused of inappropriate behavior and verbal abuse towards women, excessive alcohol use, cavorting with prostitutes and threatening to kill someone in a videotaped, incoherent rant. Ford denied many of the allegations.
At a city council meeting last week, Mayor Tory called Ford “a fighter” and said the council is pulling for him as he heads into surgery.
Ford staffer Dan Jacobs a tweeted a picture of the former mayor giving two thumbs-up while dressed in a hospital gown ahead of the operation.
---------------------------------------------------
Now, smartphone device can spot cancer faster!!!!!!
A smartphone-based device developed by researchers at Massachusetts General Hospital (MGH) can help doctors perform rapid and accurate molecular diagnosis of cancerous or non-cancerous tumours.
The device, called the D3 (digital diffraction diagnosis) system, features an imaging module with a battery-powered LED light clipped onto a standard smartphone that records high-resolution imaging data with its camera.
With a much greater field of view than traditional microscopy, the D3 system is capable of recording data on more than 100,000 cells from a blood or tissue sample in a single image.
The data can then be transmitted for analysis to a remote graphic-processing server via a secure, encrypted cloud service and the results rapidly returned to the point of care.
"We believe the platform we have developed provides essential features at an extraordinary low cost," said Cesar Castro, co-lead author of the report.
For molecular analysis of tumours, a sample of blood or tissue is labelled with microbeads that bind to known cancer-related molecules and loaded into the D3 imaging module.
After the image is recorded and data transmitted to the server, the presence of specific molecules is detected by analysing the diffraction patterns generated by the microbeads.
A pilot test of the system with cancer cell lines detected the presence of tumour proteins with an accuracy matching that of the current gold standard for molecular profiling, and the larger field of view enabled simultaneous analysis of more than 100,000 cells at a time.
"D3 analysis promptly and reliably categorised biopsy samples as high-risk, low-risk or benign with results matching those of conventional pathologic analysis," the authors noted.
In the pilot tests, results of the D3 assay were available in under an hour and at a cost of $1.80 per assay, a price that would be expected to drop with further refinement of the system.
"We expect that the D3 platform will enhance the breadth and depth of cancer screening in a way that is feasible and sustainable for resource limited-settings," added Ralph Weissleder, director of the MGH Center for Systems Biology (CSB) and co-senior author of the paper.
The report appeared in the journal PNAS Early Edition.
Brest Cancer Awarness Campaign held in Vadodara to mark Mother's Day
-------------------------------------------
UK researchers improve ovarian cancer detection test
Measuring changes in the level of a protein in the blood detects more cases of ovarian cancer than a single measurement on its own, according to the research team behind a large screening trial.
The new method, detailed in the Journal of Clinical Oncology, appears to be able to detect twice as many women with the disease than existing techniques, and could ultimately lead to routine ovarian screening.
But experts cautioned that the overall results of the trial need analysing before they will know for sure whether screening can reduce deaths from ovarian cancer.
Levels of the CA125 protein have long been used to test for ovarian cancer, but converting this knowledge into a reliable screening test has proved elusive.
The team, led by researchers at University College London (UCL), developed a calculation of ovarian cancer risk based on changing levels of the protein in women’s blood.
They used the method on samples taken from women on the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) – a 14-year-long trial of more than 200,000 UK women.
The test correctly identified more than eight out of 10 (86 per cent) women with ovarian cancer.
The conventional test, which relies on a fixed cut-off point for CA125 levels to detect the disease, generally only identifies about four in 10 women, the researchers say.
Dr James Brenton, an ovarian cancer expert at Cancer Research UK, said: “A blood test to find women at risk of ovarian cancer is an exciting prospect, but this work still needs to be tested in women to see if it can save lives.”
Many symptoms of ovarian cancer - like persistent bloating, pain in the pelvis and lower stomach, difficulty eating - are also associated with other more common conditions. This makes the disease particularly difficult to diagnose.
Dr Brenton added: “By tracking how the levels of the CA125 protein change over time we might have an early signal to detect tumours. Ovarian cancer is particularly hard to spot at an early stage so it’s vital that we find ways to diagnose the cancer sooner.”
Professor Usha Menon, trial co-ordinator at UCL commented: “There is currently no national screening programme for ovarian cancer, as research to date has been unable to provide enough evidence that any one method would improve early detection of tumours.
“These results are therefore very encouraging. They show that use of an early detection strategy based on an individual’s CA125 profile significantly improved cancer detection compared to what we’ve seen in previous screening trials.”
The team evaluated 46,237 women on the trial whose CA125 levels were analysed once a year, and a computer algorithm was used to interpret their risk of ovarian cancer.
The full results of the trial will be published later this year and should indicate whether this method will help save more lives from the disease.
---------------------------------------------------------------------
---------------------------------------------------------------------
Carrie Bickmore inspires with call to fight brain cancer
CHANNEL 10's golden girl Carrie Bickmore was awarded the Gold Logie tonight.
The Project co-host, who is currently on maternity leave after recently giving birth to her daughter Evie, used her time on stage to raise awareness for brain cancer, the disease took the life of her husband Greg Lange almost five years ago.
"Every five hours someone is diagnosed with brain cancer and eight out of 10 who are diagnosed will die of brain cancer," Bickmore said.
"It kills more people under 40 than any other cancer… no one should have to go through that."
Carrie Bickmore wears a blue beanie for brain cancer awareness during her Gold Logie acceptance speech.
She encouraged her small screen colleagues and the viewing public to wear beanies in support of brain cancer sufferers and their families, to whom she dedicated her Gold Logie.
"Please believe there will be a brighter day for you, please believe that," she said.
Her plea has now gone viral with #beaniesforbraincancer now trending on Twitter.
Most Britons unaware of skin cancer signs - survey
More than three-quarters of Britons say they would not recognise signs of skin cancer, a survey by the British Association of Dermatologists suggests.
The disease now causes about 2,100 deaths annually in the UK.
The BAD said that while 95% of people it surveyed knew the disease was becoming more common it was concerned that they appeared to be unaware of the link with sunburn.
The poll of 1,018 people last summer is being published in Sun Awareness Week.
The initiative aims to educate the public on how to check for skin cancer and provide information on sun protection techniques.
Skin cancer rates in the UK have been increasing since the 1960s, with cheaper foreign holidays and the popularity of outdoor activities thought to be responsible.
According to the BAD, more than 250,000 new cases of non-melanoma skin cancer - the most common type - are diagnosed each year, in addition to about 13,000 new cases of melanoma, the deadliest form.
The survey suggests that 85% of people are worried about the potential impact of the UK climate on skin cancer.
Some 40% said they never check their skin for signs of the disease; 77% do not feel confident that they could recognise signs of a melanoma, and 81% do not feel able to recognise signs of a non-melanoma skin cancer.
The risk of developing melanoma is said to be more than doubled in people with a history of sunburn.
And Johnathon Major from the BAD said it was "shocking" that 72% of people surveyed said they had had been sunburned in the past year.
He said: "This is a reflection of poor sun protection habits. People underestimate the damage that sunburn can do to their skin, and many think that skin reddening is just a harmless part of the tanning process, rather than a sure sign that you have damaged your skin irreparably."
While sunshine does have health benefits and aids the body's production of vitamin D for strong and healthy bones, dermatologists say it is essential to use a sunscreen, and spend time in the shade and cover up with clothing when outdoors.
No comments:
Post a Comment